In obstetrical anesthesia -beyond the field of general operative medicine -the effects of and adverse reactions to an anesthetic agent must always be evaluated with reference to twoindividuals, the mother and the infant, before a judgement can be made about the suitability or inadequacy of a new drug for obstetrical purposes [2, 5] . Once the pharmacological and general clinicalanesthetic properties of the inhalation anesthetic, Ethrane, had been extensively documented. [1, 3, 8, 9, 11, 12, 13, 15, 16, 17, 19, 22, 24, 25, 26, 27] it became necessary to investigate the adequacy or unsuitability of the drug for obstetrical procedures. In this connection it should be noted that chemically Ethrane is similar to Methoxyflurane, while pharmacologically it resembles Halothane moreclosely [11] . In contrast to the numerous papers dealing with its surgical-anesthetic properties, reports on the use of Ethrane for obstetrical anesthesia are relatively scarce. In addition to papers from South America, ( DEVOGHEL, [5] COLEMAN' [4] % and MAGNO [21] have reported their special findings in the obstetrical field. It thus appears that Ethrane relaxes the Uterus, but the effects on uterus and fetal heart rate are promptly reversible [5] . GOLEM AN [4] and MAGNO [21] have also reported satisfactory results with Ethrane. On our part, we have been publishing partial results in preliminary papers [6, 7] .
Our aim has been: l.to obtain Information on the diaplacental passage of Ethrane by measuring maternal and neonatal Ethrane blood concentrations; 2. to evaluate postnatal adjustment of the infant by the APGAR scoring System, acid-base balance and blood gas analysis.
l Method
To study possible adverse effects of anesthetic agent in the field of obstetrics, standardized anesthesia for primary Cesarean section appears to be particularly suitable, since other factors that might be mistaken for effects induced by the anesthetic agent are eliminated to a large extent. Consequently, 50 healthy mothers undergoing primary Cesarean section were given Ethrane instead of Halothane for anesthesia. Selection of the patients was based in part on the fact that the fetuses showed no evidence of imminent or manifest intrauterine manifestations. After administration of Atropine (= 0.5 mg) and pre-oxygenation in left lateral position, anesthesia was induced with 150 to 250 mg Thiopental and l mg/kg Succinylcholine. Under endotracheal intubation anesthesia was maintained until delivery of the infant, using N 2 0/02 in a 1:1 ratio, and Ethrane in a concentration of 1% by vol. on the 0300-5577/79/0007-0125$02.00average; Alcuronium Dichloride (Alloferin) was given for additional muscle relaxation. Proper gas exchange was assured by controlled hyperventilation using 9 liters/minute on the average. The maternal EGG was continuously monitored. Blood pressure and pulse rate were checked every five minutes. After delivery of the infant, the Ethrane concentration was increased to 2% by vol., and the N 2 0/0 2 ratio was changed to the usual value of 2:1. The Ethrane concentrations in the maternal blood, äs well äs maternal blood gases and acid-base balance were determined at the time of birth. Simultaneously, arterial and venous blood was cojlected from the umbilical cord for determining Ethrane concentrations, blood gases and acid-base balance. \Condition of the newborn was assessed by the APGAR scoring System. All parameters were rede termined 5,10 and 15 minutes after delivery. Ethrane concentrations were determined by gaschromatography; blood gases and acid-base balance were measured using the ASTRUP method and the SIGGAARD-ANDERSON nomogram, respectively. The newborn acid-base parameters were not corrected for the individual oxygen Saturation.
Results

l Maternal parameters
From a total of 50 available protocols, 31 were selected which provided all parameters for all points in time.
The age of the patients averaged 25.6 years, mean body weight was 71.3 kg. In 50% of cases the Cesarean section involved primiparae. Continuous ECG monitoring showed no particular features. Following induction, blood pressure dropped by an average of 10 to 20 mm Hg, corresponding to a decrease of approx. 10 to 15% from base line.
Ethrane concentrations, blood gases and acidbase balance of mothers and infants
Of a total of 50 protocols, one was excluded for being incomplete with reference to one reading; thus, 49 complete protocols were available for evaluation.
Ethrane concentrations in maternal and infant blood
Ethrane concentrations in maternal arterial blood at the time of birth averaged 6.60 mg/100 ml. Ethrane concentrations in the umbilical artery at this time were 3.03 mg/100 ml, those of the umbilical vein were 3.94 mg/100 ml. Consequently, maternal Ethrane concentrations were approximately 50% higher than the umbilical venous and more than twice äs high äs the umbilical arterial Ethrane concentrations. The umbilical venous exceeded the umbilical arterial Ethrane concentrations by 0.92 mg/100 ml ( Fig. 1 ). Base excess or base deficit in the infant blood after delivery shows the following picture: From -8.05 at the time of birth, the negative base excess improved to -7.9, -6.7, and finally to -4.6 mEq/ liter 15 minutes after birth (Fig. 12) . The condition of the infants was assessed by the APGAR scoring System, by the blood gas and acidbase balance values. At the time of birth, the usual gradients for pH, PC0 2 and P0 2 were found. These Parameters are at least partly (blood gases) dependent on the controlled Ventilation of the mother, äs demonstrated by, among other things, the fact that there was a highly significant relationship between maternal pH and umbilical venous pH, and also between maternal PCO 2 , and umbilical venous and umbilical arterial PC0 2 of the infants. The umbilical venous P0 2 depended directly on the maternal P0 2 . Similarly, there is an inverse correlation between ID-time and umbilical venous PC0 2 -the longer the time until delivery, the lower is the umbilical venous PC0 2 .
Blood gases and acid-base balance of maternal and infant blood
Since simultaneously the iipibilical venous PC0 2 , depends directly on the maternal PC0 2 , this correlation may be best explained by the decreasing maternal PC0 2 during the time until delivery.
Finally, a highly significant cörrelation was found between umbilical venous and umbilical arterial pH values, äs well äs between venous P0 2 and arterial P0 2 readings. These correlations are a direct or indirect consequence of maternal-fetal and fetal-maternal gas exchanges, and in this sense they should not be directly related to the use of Ethrane. As measured by blood gases and acid-base balance, the infants have adjusted normally during the immediate postpartum phase (up to 15 minutes). The pH increased up 7.3; r PC0 2 and P0 2 reached approximately normal levels. The initial slight metabolic acidosis gradually faded out in the coürse of the observätioü period.
Summarizing,.we mäy cönclüde from our findings that in the area of obstetrics Ethrane provides satisfactory clinical results; that Ethrane is rapidly transferred from mother tö fetus, induction-delivery-interval and matemal concentrations apparently playing a significant role only in the initial phase of Ethrane administration; that the Ethrane concentration in the postpartum phase decreases rapidly, since 15 minutes after birth the Ethrane concentration in the infants amounted only to 1/10 of the initial concentration at the time of birth; that postpartum adjustment of the infants äs measured by the APGAR scores, blood gases and acid-base balance followed normal pätterns.
These conclusions refer to the mean values äs well äs to the individual cases. Even extreme values ränge within tolerable limits; they belong to different patients. 2. Ethrane concentrations in the maternal arterial blood were 6.6 mg/100 rnl at the time of birth, in the umbilical artery they averaged 3.03 mg/100 ml, in ihe umbilical vein 3.94 mg/100 ml. In the postpartum phase, Ethrane concentrations in the infants dropped J.Perinat. Med. 7 (1979) to 0.91 mg/100 ml five minutes after birth, to 0.57 mg/100 ml 10 minutes after birth, and to 0.53 mg/ 100 ml 15 minutes after birth. A positive correlation between umbilical venous and umbilical arterial Ethiane concentrations was found. 3. Postpartum adjustment of the infants -assessed by the APGAR scores, blood gases and acid-base balancefollowed normal patterns. A positive correlation was found between maternal pH on the one band, and umbilical venous and umbilical arterial pH of the infants on the other. In addition, there was a significant correlation between umbilical venous and umbilical arterial pH. 4 
